Prestwick-983_HL60_UP
GeneID | Mean_1 | Mean_2 | StDev_1 | StDev_2 | T-Statistic | p-value | Symbol | Description | |
---|---|---|---|---|---|---|---|---|---|
1 | 952 | 2.4 | 2.4 | 0.0 | 0.1 | -0.026 | 0.9813 | CD38 | CD38 molecule |
2 | 5742 | 3.8 | 2.5 | 0.5 | 0.4 | -3.394 | 0.0283 | PTGS1 | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
3 | 8632 | 2.9 | 2.6 | 0.1 | 0.1 | -5.003 | 0.0139 | DNAH17 | dynein, axonemal, heavy chain 17 |
4 | 120 | 9.9 | 10.8 | 0.4 | 0.3 | 3.164 | 0.0365 | ADD3 | adducin 3 (gamma) |
5 | 7076 | 10.3 | 10.7 | 0.2 | 0.5 | 1.045 | 0.3836 | TIMP1 | TIMP metallopeptidase inhibitor 1 |
6 | 23315 | 9.2 | 9.4 | 0.1 | 0.6 | 0.343 | 0.7638 | SLC9A8 | solute carrier family 9, subfamily A (NHE8, cation proton antiporter 8), member 8 |
7 | 51422 | 8.5 | 10.2 | 0.3 | 0.1 | 10.769 | 0.0046 | PRKAG2 | protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
8 | 4835 | 7.6 | 8.3 | 0.2 | 0.6 | 2.013 | 0.1617 | NQO2 | NAD(P)H dehydrogenase, quinone 2 |
9 | 1124 | 2.8 | 2.6 | 0.4 | 0.1 | -0.632 | 0.5798 | CHN2 | chimerin 2 |
10 | 10443 | 11.5 | 11.4 | 0.1 | 0.4 | -0.548 | 0.6325 | N4BP2L2 | NEDD4 binding protein 2-like 2 |
11 | 11009 | 2.6 | 9.5 | 0.1 | 2.0 | 5.960 | 0.0266 | IL24 | interleukin 24 |
12 | 8437 | 6.7 | 7.3 | 0.2 | 0.1 | 5.091 | 0.0179 | RASAL1 | RAS protein activator like 1 (GAP1 like) |
13 | 79844 | 6.9 | 6.6 | 0.5 | 0.6 | -0.652 | 0.5517 | ZDHHC11 | zinc finger, DHHC-type containing 11 |
14 | 558 | 7.0 | 7.1 | 0.2 | 0.1 | 0.611 | 0.5763 | AXL | AXL receptor tyrosine kinase |
15 | 5045 | 4.7 | 5.9 | 1.0 | 0.5 | 1.952 | 0.1455 | FURIN | furin (paired basic amino acid cleaving enzyme) |
16 | 8879 | 10.9 | 11.2 | 0.1 | 0.8 | 0.556 | 0.6314 | SGPL1 | sphingosine-1-phosphate lyase 1 |
17 | 5617 | 2.3 | 2.2 | 0.0 | 0.0 | -1.482 | 0.2154 | PRL | prolactin |
18 | 1880 | 3.9 | 3.7 | 0.2 | 1.5 | -0.157 | 0.8894 | GPR183 | G protein-coupled receptor 183 |
19 | 2791 | 2.3 | 2.3 | 0.0 | 0.1 | 0.045 | 0.9679 | GNG11 | guanine nucleotide binding protein (G protein), gamma 11 |
20 | 23362 | 8.0 | 7.2 | 0.1 | 0.5 | -2.552 | 0.1210 | PSD3 | pleckstrin and Sec7 domain containing 3 |
21 | 3624 | 2.8 | 2.6 | 0.5 | 0.1 | -0.783 | 0.5063 | INHBA | inhibin, beta A |
22 | 26051 | 8.6 | 9.0 | 0.3 | 0.2 | 1.883 | 0.1376 | PPP1R16B | protein phosphatase 1, regulatory subunit 16B |
23 | 10362 | 13.5 | 12.9 | 0.2 | 0.1 | -5.244 | 0.0082 | HMG20B | high mobility group 20B |
24 | 5296 | 15.2 | 14.4 | 0.1 | 0.0 | -15.623 | 0.0005 | PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) |
25 | 868 | 6.7 | 7.0 | 0.4 | 0.2 | 1.084 | 0.3677 | CBLB | Cbl proto-oncogene B, E3 ubiquitin protein ligase |
26 | 1513 | 9.8 | 9.4 | 0.1 | 0.1 | -6.481 | 0.0042 | CTSK | cathepsin K |
27 | 6648 | 11.0 | 11.2 | 0.1 | 0.4 | 1.037 | 0.4037 | SOD2 | superoxide dismutase 2, mitochondrial |
28 | 953 | 4.4 | 4.5 | 0.1 | 0.1 | 0.913 | 0.4130 | ENTPD1 | ectonucleoside triphosphate diphosphohydrolase 1 |
29 | 8848 | 13.6 | 13.1 | 0.1 | 0.3 | -2.630 | 0.0907 | TSC22D1 | TSC22 domain family, member 1 |
30 | 2357 | 3.9 | 3.5 | 0.4 | 1.0 | -0.665 | 0.5592 | FPR1 | formyl peptide receptor 1 |
31 | 10578 | 2.4 | 2.4 | 0.1 | 0.2 | -0.319 | 0.7676 | GNLY | granulysin |
32 | 55062 | 11.8 | 11.1 | 0.1 | 0.1 | -6.742 | 0.0028 | WIPI1 | WD repeat domain, phosphoinositide interacting 1 |
33 | 10437 | 13.4 | 13.8 | 0.1 | 0.6 | 0.969 | 0.4321 | IFI30 | interferon, gamma-inducible protein 30 |
34 | 57509 | 8.0 | 7.0 | 0.1 | 0.1 | -12.545 | 0.0003 | MTUS1 | microtubule associated tumor suppressor 1 |
35 | 9047 | 6.8 | 6.8 | 0.2 | 0.2 | 0.144 | 0.8925 | SH2D2A | SH2 domain containing 2A |
36 | 23768 | 2.8 | 2.3 | 0.9 | 0.0 | -0.974 | 0.4325 | FLRT2 | fibronectin leucine rich transmembrane protein 2 |
37 | 23288 | 10.4 | 10.4 | 0.2 | 0.1 | -0.525 | 0.6436 | IQCE | IQ motif containing E |
38 | 23597 | 10.1 | 10.5 | 0.2 | 0.1 | 3.440 | 0.0441 | ACOT9 | acyl-CoA thioesterase 9 |
39 | 1992 | 11.6 | 11.7 | 0.1 | 0.4 | 0.287 | 0.8003 | SERPINB1 | serpin peptidase inhibitor, clade B (ovalbumin), member 1 |
40 | 57406 | 7.7 | 7.5 | 0.2 | 0.4 | -0.537 | 0.6334 | ABHD6 | abhydrolase domain containing 6 |
41 | 10855 | 5.8 | 5.4 | 0.4 | 1.2 | -0.482 | 0.6704 | HPSE | heparanase |
42 | 654 | 2.7 | 4.8 | 0.5 | 1.1 | 3.058 | 0.0656 | BMP6 | bone morphogenetic protein 6 |
43 | 26037 | 12.4 | 12.5 | 0.1 | 0.1 | 1.931 | 0.1260 | SIPA1L1 | signal-induced proliferation-associated 1 like 1 |
44 | 6446 | 7.0 | 8.8 | 0.5 | 0.1 | 6.735 | 0.0126 | SGK1 | serum/glucocorticoid regulated kinase 1 |
45 | 8496 | 8.6 | 7.9 | 0.1 | 0.4 | -2.802 | 0.1012 | PPFIBP1 | PTPRF interacting protein, binding protein 1 (liprin beta 1) |
46 | 10924 | 9.1 | 8.9 | 0.0 | 0.4 | -1.025 | 0.4123 | SMPDL3A | sphingomyelin phosphodiesterase, acid-like 3A |
47 | 85458 | 8.7 | 7.7 | 0.1 | 0.4 | -4.155 | 0.0392 | DIXDC1 | DIX domain containing 1 |
48 | 55930 | 9.4 | 9.9 | 0.1 | 0.1 | 4.742 | 0.0092 | MYO5C | myosin VC |
49 | 56925 | 13.0 | 11.8 | 0.5 | 0.3 | -3.592 | 0.0360 | LXN | latexin |
50 | 138050 | 8.2 | 6.7 | 0.1 | 0.2 | -9.756 | 0.0014 | HGSNAT | heparan-alpha-glucosaminide N-acetyltransferase |
51 | 2010 | 10.2 | 10.1 | 0.2 | 0.3 | -0.492 | 0.6532 | EMD | emerin |
52 | 3587 | 5.3 | 2.6 | 1.0 | 0.3 | -4.678 | 0.0289 | IL10RA | interleukin 10 receptor, alpha |
53 | 6709 | 10.3 | 9.6 | 0.1 | 0.1 | -6.403 | 0.0032 | SPTAN1 | spectrin, alpha, non-erythrocytic 1 |
54 | 9846 | 10.0 | 8.9 | 0.4 | 0.4 | -3.325 | 0.0310 | GAB2 | GRB2-associated binding protein 2 |
55 | 9732 | 2.3 | 5.1 | 0.0 | 1.0 | 4.948 | 0.0384 | DOCK4 | dedicator of cytokinesis 4 |
56 | 1318 | 9.0 | 8.8 | 0.2 | 0.6 | -0.477 | 0.6730 | SLC31A2 | solute carrier family 31 (copper transporter), member 2 |
57 | 79713 | 11.0 | 10.4 | 0.1 | 1.2 | -0.991 | 0.4248 | IGFLR1 | IGF-like family receptor 1 |
58 | 64092 | 2.3 | 2.3 | 0.0 | 0.1 | -0.195 | 0.8565 | SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 |
59 | 3914 | 6.5 | 7.0 | 0.8 | 0.4 | 0.899 | 0.4400 | LAMB3 | laminin, beta 3 |
60 | 10144 | 3.4 | 4.1 | 0.8 | 0.5 | 1.225 | 0.2999 | FAM13A | family with sequence similarity 13, member A |
61 | 22822 | 4.4 | 3.3 | 0.1 | 0.2 | -7.377 | 0.0059 | PHLDA1 | pleckstrin homology-like domain, family A, member 1 |
62 | 10123 | 8.3 | 6.0 | 0.0 | 0.8 | -5.357 | 0.0328 | ARL4C | ADP-ribosylation factor-like 4C |
63 | 3554 | 6.0 | 2.7 | 0.6 | 0.1 | -9.908 | 0.0074 | IL1R1 | interleukin 1 receptor, type I |
64 | 55859 | 2.4 | 2.4 | 0.0 | 0.1 | 0.096 | 0.9310 | BEX1 | brain expressed, X-linked 1 |
65 | 83988 | 3.4 | 2.8 | 0.1 | 0.0 | -12.605 | 0.0025 | NCALD | neurocalcin delta |
66 | 4907 | 3.0 | 2.7 | 0.3 | 0.3 | -1.585 | 0.1886 | NT5E | 5'-nucleotidase, ecto (CD73) |
67 | 7057 | 8.2 | 9.5 | 0.1 | 0.2 | 8.524 | 0.0069 | THBS1 | thrombospondin 1 |
68 | 29992 | 9.7 | 10.1 | 0.2 | 0.2 | 3.483 | 0.0254 | PILRA | paired immunoglobin-like type 2 receptor alpha |
69 | 55556 | 11.4 | 11.3 | 0.0 | 0.4 | -0.598 | 0.6097 | ENOSF1 | enolase superfamily member 1 |
70 | 6367 | 2.5 | 2.6 | 0.0 | 0.4 | 0.644 | 0.5855 | CCL22 | chemokine (C-C motif) ligand 22 |
71 | 2669 | 4.3 | 5.3 | 0.6 | 1.0 | 1.452 | 0.2383 | GEM | GTP binding protein overexpressed in skeletal muscle |
72 | 23236 | 7.2 | 7.6 | 0.1 | 0.2 | 2.366 | 0.0956 | PLCB1 | phospholipase C, beta 1 (phosphoinositide-specific) |
73 | 648740 | 10.8 | 11.0 | 0.2 | 0.4 | 0.942 | 0.4174 | ACTG1P4 | actin gamma 1 pseudogene 4 |
74 | 3566 | 5.5 | 5.3 | 0.7 | 0.5 | -0.295 | 0.7841 | IL4R | interleukin 4 receptor |
75 | 2353 | 7.0 | 8.7 | 0.4 | 0.7 | 3.877 | 0.0281 | FOS | FBJ murine osteosarcoma viral oncogene homolog |
76 | 667 | 6.2 | 7.0 | 0.1 | 0.1 | 6.619 | 0.0030 | DST | dystonin |
77 | 3784 | 3.9 | 4.2 | 0.5 | 0.3 | 0.796 | 0.4813 | KCNQ1 | potassium channel, voltage gated KQT-like subfamily Q, member 1 |
78 | 3017 | 11.5 | 11.4 | 0.1 | 0.2 | -0.284 | 0.7991 | HIST1H2BD | histone cluster 1, H2bd |
79 | 3669 | 9.9 | 13.5 | 0.4 | 0.2 | 14.181 | 0.0003 | ISG20 | interferon stimulated exonuclease gene 20kDa |
80 | 1836 | 8.0 | 12.6 | 0.2 | 0.6 | 12.017 | 0.0032 | SLC26A2 | solute carrier family 26 (anion exchanger), member 2 |
81 | 6775 | 3.1 | 2.7 | 0.6 | 0.3 | -0.936 | 0.4264 | STAT4 | signal transducer and activator of transcription 4 |
82 | 1284 | 7.8 | 6.4 | 0.1 | 0.0 | -17.375 | 0.0017 | COL4A2 | collagen, type IV, alpha 2 |
83 | 29940 | 8.6 | 8.3 | 0.1 | 0.4 | -1.507 | 0.2461 | DSE | dermatan sulfate epimerase |
84 | 7280 | 7.9 | 9.0 | 0.4 | 1.2 | 1.575 | 0.2364 | TUBB2A | tubulin, beta 2A class IIa |
85 | 81575 | 6.8 | 6.5 | 0.4 | 0.4 | -0.729 | 0.5078 | APOLD1 | apolipoprotein L domain containing 1 |
86 | 55790 | 3.5 | 2.4 | 1.2 | 0.1 | -1.554 | 0.2589 | CSGALNACT1 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
87 | 3557 | 5.0 | 6.3 | 0.4 | 0.4 | 4.434 | 0.0117 | IL1RN | interleukin 1 receptor antagonist |
88 | 5359 | 8.7 | 10.2 | 0.2 | 0.3 | 6.649 | 0.0049 | PLSCR1 | phospholipid scramblase 1 |
89 | 51593 | 10.1 | 10.3 | 0.2 | 0.6 | 0.725 | 0.5324 | SRRT | serrate, RNA effector molecule |
90 | 6383 | 3.1 | 2.4 | 0.1 | 0.1 | -8.841 | 0.0009 | SDC2 | syndecan 2 |
91 | 3685 | 10.4 | 10.1 | 0.0 | 0.1 | -7.867 | 0.0083 | ITGAV | integrin, alpha V |
92 | 1390 | 7.5 | 9.2 | 0.1 | 0.3 | 9.823 | 0.0035 | CREM | cAMP responsive element modulator |
93 | 7799 | 5.5 | 5.6 | 0.2 | 0.1 | 1.024 | 0.3776 | PRDM2 | PR domain containing 2, with ZNF domain |
94 | 8277 | 5.2 | 4.4 | 1.0 | 0.4 | -1.388 | 0.2743 | TKTL1 | transketolase-like 1 |
95 | 278 | 6.2 | 4.5 | 0.2 | 1.3 | -2.154 | 0.1584 | AMY1C | amylase, alpha 1C (salivary) |
96 | 54900 | 2.6 | 2.6 | 0.1 | 0.3 | -0.164 | 0.8807 | LAX1 | lymphocyte transmembrane adaptor 1 |
97 | 9467 | 9.9 | 10.5 | 0.2 | 0.1 | 5.150 | 0.0093 | SH3BP5 | SH3-domain binding protein 5 (BTK-associated) |
98 | 901 | 6.3 | 5.7 | 0.7 | 0.3 | -1.514 | 0.2416 | CCNG2 | cyclin G2 |
99 | 11214 | 10.0 | 9.6 | 0.1 | 0.2 | -3.233 | 0.0610 | AKAP13 | A kinase (PRKA) anchor protein 13 |
100 | 154881 | 2.3 | 2.7 | 0.0 | 0.8 | 0.983 | 0.4290 | KCTD7 | potassium channel tetramerization domain containing 7 |
101 | 55784 | 2.6 | 2.6 | 0.1 | 0.3 | -0.008 | 0.9945 | MCTP2 | multiple C2 domains, transmembrane 2 |
102 | 6653 | 11.9 | 11.9 | 0.1 | 0.6 | 0.155 | 0.8902 | SORL1 | sortilin-related receptor, L(DLR class) A repeats containing |
103 | 374 | 6.2 | 12.7 | 0.4 | 0.9 | 12.056 | 0.0017 | AREG | amphiregulin |
104 | 9435 | 2.5 | 2.5 | 0.1 | 0.2 | -0.346 | 0.7483 | CHST2 | carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2 |
105 | 694 | 10.6 | 9.8 | 0.1 | 0.6 | -2.225 | 0.1537 | BTG1 | B-cell translocation gene 1, anti-proliferative |
106 | 7941 | 2.3 | 2.4 | 0.0 | 0.1 | 1.458 | 0.2627 | PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
107 | 942 | 8.0 | 7.6 | 0.3 | 0.1 | -2.296 | 0.1215 | CD86 | CD86 molecule |
108 | 8837 | 8.3 | 8.5 | 0.2 | 0.1 | 2.587 | 0.0927 | CFLAR | CASP8 and FADD-like apoptosis regulator |
109 | 3386 | 3.4 | 3.0 | 0.3 | 0.6 | -0.944 | 0.4114 | ICAM4 | intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) |
110 | 57804 | 14.6 | 13.6 | 0.3 | 0.4 | -3.346 | 0.0369 | POLD4 | polymerase (DNA-directed), delta 4, accessory subunit |
111 | 7035 | 5.2 | 3.4 | 0.5 | 0.8 | -3.215 | 0.0410 | TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
112 | 1846 | 7.6 | 9.1 | 0.3 | 0.5 | 4.351 | 0.0192 | DUSP4 | dual specificity phosphatase 4 |
113 | 2495 | 16.6 | 17.1 | 0.3 | 0.2 | 2.412 | 0.0877 | FTH1 | ferritin, heavy polypeptide 1 |
114 | 23136 | 2.9 | 2.6 | 0.5 | 0.2 | -1.058 | 0.3701 | EPB41L3 | erythrocyte membrane protein band 4.1-like 3 |
115 | 4600 | 5.2 | 5.4 | 0.2 | 0.8 | 0.476 | 0.6765 | MX2 | MX dynamin-like GTPase 2 |
116 | 100996724 | 6.4 | 5.8 | 0.3 | 0.3 | -2.463 | 0.0714 | LOC100996724 | phosphodiesterase 4D interacting protein-like |
117 | 27342 | 9.2 | 9.8 | 0.3 | 0.1 | 3.469 | 0.0655 | RABGEF1 | RAB guanine nucleotide exchange factor (GEF) 1 |
118 | 6304 | 10.7 | 2.4 | 0.0 | 0.1 | -162.687 | 0.0000 | SATB1 | SATB homeobox 1 |
119 | 9929 | 12.3 | 12.1 | 0.2 | 0.1 | -1.328 | 0.2854 | JOSD1 | Josephin domain containing 1 |
120 | 57476 | 3.2 | 2.2 | 1.7 | 0.0 | -0.994 | 0.4251 | GRAMD1B | GRAM domain containing 1B |
121 | 3995 | 6.8 | 8.8 | 0.2 | 0.7 | 4.314 | 0.0343 | FADS3 | fatty acid desaturase 3 |
122 | 7227 | 12.6 | 10.2 | 0.2 | 0.2 | -15.010 | 0.0001 | TRPS1 | trichorhinophalangeal syndrome I |
123 | 84159 | 7.0 | 7.2 | 0.3 | 0.3 | 0.806 | 0.4659 | ARID5B | AT rich interactive domain 5B (MRF1-like) |
124 | 55568 | 10.7 | 10.1 | 0.2 | 0.4 | -2.527 | 0.0935 | GALNT10 | polypeptide N-acetylgalactosaminyltransferase 10 |
125 | 3589 | 5.7 | 6.0 | 0.1 | 0.2 | 3.172 | 0.0345 | IL11 | interleukin 11 |
126 | 9144 | 13.6 | 12.5 | 0.0 | 0.3 | -5.220 | 0.0328 | SYNGR2 | synaptogyrin 2 |
127 | 3399 | 10.9 | 10.6 | 0.3 | 0.2 | -1.422 | 0.2451 | ID3 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
128 | 104 | 8.1 | 8.5 | 0.4 | 0.2 | 1.442 | 0.2503 | ADARB1 | adenosine deaminase, RNA-specific, B1 |
129 | 9659 | 6.5 | 6.1 | 0.1 | 0.4 | -2.109 | 0.1536 | PDE4DIP | phosphodiesterase 4D interacting protein |
130 | 126321 | 7.9 | 8.9 | 0.1 | 0.3 | 5.772 | 0.0170 | MFSD12 | major facilitator superfamily domain containing 12 |
131 | 19 | 3.0 | 2.5 | 0.6 | 0.2 | -1.380 | 0.2854 | ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 |
132 | 60370 | 10.4 | 11.2 | 0.1 | 0.6 | 2.247 | 0.1442 | AVPI1 | arginine vasopressin-induced 1 |
133 | 5141 | 7.8 | 6.4 | 0.1 | 0.1 | -14.258 | 0.0001 | PDE4A | phosphodiesterase 4A, cAMP-specific |
134 | 5142 | 4.3 | 7.0 | 1.5 | 0.2 | 3.266 | 0.0787 | PDE4B | phosphodiesterase 4B, cAMP-specific |
135 | 5144 | 4.6 | 3.7 | 0.2 | 0.8 | -1.988 | 0.1649 | PDE4D | phosphodiesterase 4D, cAMP-specific |
136 | 54436 | 3.6 | 3.8 | 0.1 | 0.5 | 0.692 | 0.5571 | SH3TC1 | SH3 domain and tetratricopeptide repeats 1 |
137 | 10112 | 9.9 | 10.3 | 0.3 | 0.6 | 0.809 | 0.4764 | KIF20A | kinesin family member 20A |
138 | 5343 | 7.1 | 6.4 | 0.1 | 0.7 | -1.445 | 0.2827 | PLGLB1 | plasminogen-like B1 |
139 | 6303 | 7.9 | 9.2 | 0.4 | 0.8 | 2.437 | 0.0899 | SAT1 | spermidine/spermine N1-acetyltransferase 1 |
140 | 90 | 7.2 | 8.1 | 0.1 | 0.2 | 7.592 | 0.0055 | ACVR1 | activin A receptor, type I |
141 | 669 | 8.4 | 9.3 | 0.3 | 0.3 | 3.361 | 0.0283 | BPGM | 2,3-bisphosphoglycerate mutase |
142 | 3149 | 10.3 | 10.7 | 0.2 | 0.4 | 1.472 | 0.2408 | HMGB3 | high mobility group box 3 |
143 | 965 | 7.9 | 8.6 | 0.3 | 0.3 | 2.378 | 0.0771 | CD58 | CD58 molecule |
144 | 1462 | 2.5 | 2.4 | 0.4 | 0.1 | -0.649 | 0.5786 | VCAN | versican |
145 | 2308 | 8.2 | 6.7 | 0.4 | 0.1 | -6.362 | 0.0136 | FOXO1 | forkhead box O1 |
146 | 5608 | 8.6 | 3.5 | 0.1 | 0.3 | -27.551 | 0.0001 | MAP2K6 | mitogen-activated protein kinase kinase 6 |
147 | 274 | 4.4 | 4.9 | 0.5 | 0.7 | 1.193 | 0.3043 | BIN1 | bridging integrator 1 |
148 | 23231 | 8.8 | 9.6 | 0.1 | 0.2 | 6.714 | 0.0157 | SEL1L3 | sel-1 suppressor of lin-12-like 3 (C. elegans) |
149 | 3122 | 3.4 | 2.4 | 0.6 | 0.0 | -2.701 | 0.1130 | HLA-DRA | major histocompatibility complex, class II, DR alpha |
150 | 8942 | 6.9 | 10.6 | 0.4 | 0.1 | 15.658 | 0.0033 | KYNU | kynureninase |
151 | 23710 | 6.6 | 5.6 | 0.6 | 0.2 | -2.450 | 0.1132 | GABARAPL1 | GABA(A) receptor-associated protein like 1 |
152 | 427 | 12.6 | 11.4 | 0.1 | 0.4 | -5.258 | 0.0249 | ASAH1 | N-acylsphingosine amidohydrolase (acid ceramidase) 1 |
153 | 8895 | 9.2 | 7.8 | 0.3 | 0.4 | -4.679 | 0.0135 | CPNE3 | copine III |
154 | 5447 | 12.5 | 12.9 | 0.2 | 0.1 | 3.525 | 0.0359 | POR | P450 (cytochrome) oxidoreductase |
155 | 23180 | 5.3 | 6.0 | 0.3 | 0.4 | 2.194 | 0.0982 | RFTN1 | raftlin, lipid raft linker 1 |
156 | 117247 | 4.6 | 4.6 | 0.5 | 1.1 | -0.001 | 0.9992 | SLC16A10 | solute carrier family 16 (aromatic amino acid transporter), member 10 |
157 | 5860 | 8.9 | 9.0 | 0.0 | 0.2 | 0.414 | 0.7166 | QDPR | quinoid dihydropteridine reductase |
158 | 9456 | 5.7 | 6.5 | 0.3 | 0.5 | 2.171 | 0.1061 | HOMER1 | homer homolog 1 (Drosophila) |
159 | 1508 | 8.9 | 8.2 | 0.2 | 0.1 | -6.816 | 0.0120 | CTSB | cathepsin B |
160 | 11252 | 8.3 | 8.8 | 0.3 | 0.2 | 2.121 | 0.1047 | PACSIN2 | protein kinase C and casein kinase substrate in neurons 2 |
161 | 5368 | 2.6 | 2.6 | 0.2 | 0.4 | 0.087 | 0.9363 | PNOC | prepronociceptin |
162 | 302 | 9.3 | 9.9 | 0.8 | 0.3 | 1.224 | 0.3216 | ANXA2 | annexin A2 |
163 | 4929 | 6.0 | 6.8 | 0.1 | 0.0 | 18.498 | 0.0001 | NR4A2 | nuclear receptor subfamily 4, group A, member 2 |
164 | 8013 | 4.3 | 3.6 | 0.5 | 0.4 | -1.930 | 0.1280 | NR4A3 | nuclear receptor subfamily 4, group A, member 3 |
165 | 3164 | 2.3 | 2.4 | 0.0 | 0.1 | 1.029 | 0.4036 | NR4A1 | nuclear receptor subfamily 4, group A, member 1 |
166 | 100129518 | 4.9 | 4.5 | 0.4 | 0.4 | -1.358 | 0.2464 | LOC100129518 | uncharacterized LOC100129518 |
167 | 6498 | 8.6 | 8.7 | 0.1 | 0.2 | 0.525 | 0.6301 | SKIL | SKI-like proto-oncogene |
168 | 9267 | 8.6 | 8.3 | 0.2 | 0.4 | -1.304 | 0.2910 | CYTH1 | cytohesin 1 |
169 | 1495 | 11.0 | 11.6 | 0.1 | 0.1 | 6.951 | 0.0054 | CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa |
170 | 54498 | 6.0 | 10.6 | 0.1 | 0.3 | 24.960 | 0.0001 | SMOX | spermine oxidase |
171 | 11031 | 9.8 | 9.5 | 0.3 | 0.5 | -0.948 | 0.4085 | RAB31 | RAB31, member RAS oncogene family |
172 | 4973 | 2.4 | 2.3 | 0.0 | 0.1 | -1.379 | 0.2478 | OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
173 | 27242 | 8.6 | 9.5 | 0.4 | 0.3 | 2.827 | 0.0521 | TNFRSF21 | tumor necrosis factor receptor superfamily, member 21 |
174 | 6310 | 5.0 | 6.6 | 0.5 | 0.9 | 2.758 | 0.0710 | ATXN1 | ataxin 1 |
175 | 2517 | 9.1 | 9.2 | 0.1 | 0.2 | 0.497 | 0.6584 | FUCA1 | fucosidase, alpha-L- 1, tissue |
176 | 55701 | 9.4 | 6.6 | 0.2 | 0.9 | -5.242 | 0.0303 | ARHGEF40 | Rho guanine nucleotide exchange factor (GEF) 40 |